US FDA expands approval for J&J's drug for rare blood disorder
JNJ•FDA approves expanded use of Johnson & Johnson drug
Aug. 24 (Reuters) - The U.S. Food and Drug Administration has approved the expanded use of Johnson & Johnson's JNJ.N drug to treat a rare blood disorder, the company said on Monday.
